Clinical Study
Successful Treatment in Children with Hodgkin Lymphoma in Greece; A 20-Year Experience in a Single Institution
Table 4
Characteristics of patients with second or third malignancy.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
∗months from diagnosis, MC: mixed cellularity, LD: lymphocyte depletion, LP: lymphocytic predominant, NS: nodular sclerosis. CT: chemotherapy, RT: radiotherapy, NED: no evidence of disease. Thyroid cancer. Thyroid cancer. Thyroid cancer (2nd) and Osteosarcoma (3rd) 94 months from diagnosis. |